Page last updated: 2024-10-30

metformin and Adhalinopathies

metformin has been researched along with Adhalinopathies in 1 studies

Metformin: A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289)
metformin : A member of the class of guanidines that is biguanide the carrying two methyl substituents at position 1.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hammers, DW1

Other Studies

1 other study available for metformin and Adhalinopathies

ArticleYear
RevAMP(K)ing Mitochondria for Sarcoglycanopathy Therapeutics.
    Circulation. Heart failure, 2019, Volume: 12, Issue:4

    Topics: Autophagy; Cardiomyopathy, Dilated; Heart Failure; Humans; Metformin; Mitochondria; Muscle, Skeletal

2019